Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2018-05-18 Investor Presentation
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
关于召开网上投资者交流会的通知
Investor Presentation Classification · 85% confidence The document is a notice about an upcoming online investor communication meeting scheduled for May 23, 2018. It invites investors to participate and mentions that the company will disclose the meeting's content afterward. The document does not contain financial statements, detailed financial data, or results. It is an announcement of an event rather than a report or transcript. Therefore, it fits best as an Investor Presentation (IP) or possibly a Regulatory Filing (RNS). However, since it is specifically about an investor communication meeting and not a full presentation document, the closest category is Investor Presentation (IP).
2018-05-18 Chinese
关于更换持续督导保荐代表人、持续督导财务顾问主办人的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Huabang Life Health Co., Ltd. regarding the replacement of continuous supervision sponsors and financial advisors for certain projects. It details personnel changes in the roles of continuous supervision representatives and financial advisors related to specific financing and acquisition projects. The document does not contain financial statements, earnings data, or detailed financial analysis. It is a regulatory announcement about management changes in advisory roles related to ongoing supervision of projects. Therefore, it fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2018-05-15 Chinese
向特定对象发行股份购买资产的限售股份上市流通的提示性公告
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the lifting of restrictions on certain shares issued to specific parties as part of an asset purchase transaction. It includes information about the number of shares becoming tradable, the shareholders involved, their commitments, and the fulfillment of profit compensation agreements. The document references regulatory approval from the China Securities Regulatory Commission and provides detailed tables on shareholding and lock-up periods. It is not a financial report, earnings release, or management discussion but rather a formal announcement about share circulation and compliance with lock-up agreements related to a specific capital transaction. This fits the category of a Share Issue/Capital Change announcement, as it deals with the listing and circulation of restricted shares issued in a private placement for asset acquisition.
2018-05-13 Chinese
关于首次回购公司股份的公告
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from Huabang Life Health Co., Ltd. regarding the company's first repurchase of its own shares. It details the dates of board and shareholder meetings approving the repurchase, references relevant stock exchange rules, and provides specifics about the number of shares repurchased, prices, and total amount paid. The document is short (732 characters) and focuses solely on the share buyback event. This matches the definition of a 'Transaction in Own Shares' filing, which reports on the company's repurchase of its own shares. There is no indication that this is a full financial report, earnings release, or other type of filing. Therefore, the correct classification is POS (Transaction in Own Shares).
2018-05-08 Chinese
关于“中小板问询函【2018】第278号”问询函相关问题的说明公告
Regulatory Filings Classification · 95% confidence The document is a detailed explanation and response to an inquiry letter (问询函) from the Shenzhen Stock Exchange regarding the company's control and investment in another company, including detailed descriptions of shareholding, board composition, management influence, and strategic investment intentions. It is an official announcement clarifying regulatory questions rather than a financial report or earnings release. The document is over 6,000 characters and contains substantive content but is not a financial statement or audit report. It does not present quarterly or annual financial results, nor is it a transcript or presentation. It is a regulatory announcement responding to an inquiry letter, which fits best under Regulatory Filings (RNS).
2018-05-08 Chinese
更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement related to previously published reports: the 2017 Annual Report, a special report on the use and storage of raised funds, and an assurance report on the same. It contains detailed corrections to financial data and disclosures originally published on April 28, 2018. The document explicitly states it is a "更正公告" (Correction Announcement) and does not contain the full original reports but corrections to them. The length is over 10,000 characters, indicating substantive content, but the nature of the document is to correct previously issued reports rather than being the original report itself. This fits best under Regulatory Filings (RNS) as it is a regulatory announcement correcting prior filings rather than the full Annual Report (10-K) or the assurance report itself. It is not a report publication announcement (RPA) because it contains detailed corrections, not just a notice of publication. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2018-05-08 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.